Norwegian biotech company Hofseth starts clinical trials using farmed salmon oil as COVID-19 treatment

If phase two succeeds, the company will escalate the clinical trial to phase three with 600 patients.

Hofseth BioCare CFO Jon Olav Odegard.
Hofseth BioCare CFO Jon Olav Odegard.Photo: Anders Furuset
Published 30 June 2020, 10:24Updated 30 June 2020, 20:11